New 20 minute procedure designed to reduce to eliminate chronic heartburn symptoms and medication use...good news for patients with GERD...BD
NDO Surgical, Inc. (NDO) announced that the US Food and Drug Administration (FDA) cleared the Company's Plicator II(TM) multiple implant technology for immediate sale and distribution. Plicator II technology offers improved outcomes for harder-to-treat gastroesophageal reflux disease (GERD) patients.
The Full-Thickness Plicator™ procedure is a non-surgical, endoscopic GERD treatment based
on the proven principles of anti-reflux surgery. The procedure allows the physician to create a full-thickness plication at the gastroesophageal junction under direct endoscopic visualization; enhancing the competency of the gastric cardia and restoring the normal anti-reflux barrier. Patients are treated on an outpatient basis and usually are able to return to normal activities the following day.
NDO Receives FDA 510(K) Clearance For Plicator II(TM)
http://www.ndosurgical.com/patient_portal/plicator_procedure.htm
0 comments :
Post a Comment